Navigation Links
WallSt.net Updates Investment Community Through All-New Interview With Transplant Creations
Date:1/16/2008

NEW YORK, Jan. 16 /PRNewswire/ -- On January 10, Dr. Marlies Van Hoef, CEO of Transplant Creations (http://www.transplantcreations.com) updated the investment community in an all-new interview with http://www.wallst.net. Topics covered in the interview include an overview of the company, recent press, the market opportunity and upcoming milestones for which investors should watch.

To hear the interview in its entirety, visit the Company website at http://www.transplantcreations.com or go to http://www.wallst.net/audio/audio.asp?ticker=PRIVATE&id=4341.

About Transplant Creations:

Experienced in evaluation of the therapeutic potential of products, Transplant Creations' service department provides advice in strategic planning during the preclinical stage of development, during early or late stage clinical development, or at a moment that companies consider acquisition or development of a product in a therapeutic area within our focus.

Specialized in hematopoietic stem cell transplantation with a focus on malignant diseases and a back-ground in oncology and hematology the Company has developed a unique "delivery method" for "drug combinations", autologous stem cell support and allogeneic hematopoietic stem cell grafting.

The investment sector has been focusing on drugs and technologies as targets for investment, said Van Hoef, we focus on method development through same clinical research principles as drug development.

Van Hoef emphasized that there is an opportunity for investment in methods that has remained unexplored. The Company's unique method offers superior perspectives for disease outcome.

The mission for 2008 and beyond is to invite investors and the public to get involved in implementation of the method.

For more information, please visit http://www.transplantcreations.com.

About WallSt.net:

http://www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. The Web site is a leading provider of timely business news, executive interviews, multimedia content and research tools. Financial Media Group, Inc. also owns http://www.mywallst.net, a financial social network for investors, and Financial Filings Corp., a provider of compliance solutions to publicly traded companies. Additionally, WallStreet Direct, Inc. owns and operates WallStRadio, a business and finance podcast Web site. Financial Filings Corp. is expecting to receive two hundred eighty dollars from Transplant Creations for the dissemination of this press release. For a complete list of our advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp.

Contact: WallSt.net

800-4-WALLST


'/>"/>
SOURCE WallStreet Direct, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WallSt.net Announces Upcoming Interview With CEO of Avicena Group
2. WallSt.net Announces Upcoming Interview with CSO and COO of Urigen Pharmaceuticals
3. WallSt.net Announces Upcoming Interview With CEO of Alliance HealthCard
4. Skystar Bio-Pharmaceutical Announces Upcoming Interview With WallSt.net ( www.wallst.net )
5. WallSt.net (www.wallst.net) Updates the Investment Community Through All-New Interviews With XMDC, POSS and TYPE
6. WallSt.net Updates Investment Community Through All-New Interview With XTend Medical
7. WallSt.net Updates Investment Community Through All-New Interview With Ingen Technologies
8. PPD Updates 2007 Forecast; Issues Financial Guidance for 2008
9. Cardiome Updates Guidance
10. Silverchair Learning Systems Updates and Develops New Courses
11. eDiets.com(R) Updates Timing of Third Quarter 2007 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... January 17, 2017 , ... Livionex, Inc., a Silicon Valley healthcare company ... clinical study for its dental gel that shows significant reduction in plaque levels and ... triclosan. The study was conducted at the Beckman Laser Institute at UC Irvine and ...
(Date:1/17/2017)... ... 17, 2017 , ... Lynx Technology Partners (Lynx), ... security companies for consecutive years, today announced the appointment of four members to ... nomination process to a close and positions Lynx for even faster growth in ...
(Date:1/16/2017)... ... January 17, 2017 , ... ... an internationally recognized leader in the fast-casual category, announces a hearty and wholesome ... Good Egg Breakfast Sandwich, Turkey Mash-Up Sandwich, Cranberry Crunch & Honey Parfait, Slow ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... demonstrate their groundbreaking GunSport•PRO® and EB15•LE® electronic earplugs at the NSSF SHOT Show ... Vegas, Booth #2809. The SHOT Show is the shooting, hunting and outdoor trade ...
(Date:1/16/2017)... ... 16, 2017 , ... As New York’s fastest growing ophthalmic ... to their medical staff, according to eye surgeon, Jeffrey Martin, MD, FACS, Chief ... division of SightMD. Dr. Giamos will practice primarily out of SightMD’s Riverhead, Southampton, ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... PARSIPPANY, N.J. , Jan. 17, 2017 Interpace ... that provides clinically useful molecular diagnostic tests and pathology ... it has received a letter dated January 13, 2017 ... it has regained compliance with the requirement of the ... price of $1.00 per share. The letter ...
(Date:1/17/2017)... Research and Markets has announced the addition of the "The Top ... ... and profiles the leading 200 manufacturers and distributors of molecular diagnostics products ... United States and Europe to ... Profile information for each company in The Top 200 Molecular Diagnostics ...
(Date:1/17/2017)... , January 17, 2017 ... 2016;11(Suppl. 1):2-4 ; http://www.touchneurology.com/articles/tailored-temperature-management-neurocritical-care ... ... Published recently in European Neurological ... touchNEUROLOGY, Catherine Amey reports that despite ...
Breaking Medicine Technology: